Radian Group amends Everbank repurchase agreement, lowers borrowing cap

Radian reduced the maximum borrowing under its Everbank master repurchase agreement to $25.0M via a second amendment, while retaining the parent guaranty and most other terms. The company reported Q4 2025 EPS of $1.16 versus a $1.08 consensus (≈7.4% beat) and revenue of $301M vs $300.53M expected, prompting an after-hours stock rise. Radian trades with a $4.5B market cap, P/E of 7.56 and a 3.09% dividend yield; InvestingPro flags it as undervalued. The repurchase limit cut is a modest liquidity change but the earnings beat is the primary near-term driver for the equity.

Analysis

The cutback in bank-funded repo capacity should be read as a funding mix decision rather than a pure liquidity failure — it mechanically forces the firm to accelerate use of capital-markets funding and whole-loan sales. That shift reduces short-term earnings volatility from counterparty lines but compresses incremental margin because securitization and third-party warehouse economics typically carry higher upfront fees and execution timing risk.

Earnings strength points to underwriting resilience and operating leverage in the core mortgage insurance book, but that resilience is conditional on stable MBS spreads and origination volume; a persistent widening in spreads or a drop in originations will translate quickly into lower fee capture and higher funding costs. Watch the interplay between funding price repricing and reserve trajectory: even small tick-ups in secured funding rates erode net income more than headlines imply because of the leverage on the servicing/securitization pipeline.

Short timeline catalysts are repo-renewal commentary and MBS spread moves over the next 0–3 months; medium-term (3–12 months) drivers include origination volumes, reserve cadence, and any changes to capital-return policy. Tail risks include a sudden warehouse lender stress event or a broad MBS liquidity shock that forces accelerated asset sales; these would bite equity hard and could invalidate dividend assumptions within a single quarter.

Key Decisions for Investors

• Long RDN equity sized 2–4% of portfolio + buy 6-month put ~10% OTM to limit downside to ~10–12%; thesis: funding normalization + continued underwriting performance re-rates valuation for 20–30% upside over 6–12 months; cost of hedge is the main drag (expect ~2–4% drag on position).
• Call-spread (bull call) on RDN 9–12 month: buy nearer-term call and sell a higher strike to fund ~50–70% of premium; target asymmetric payoff 2:1 to 3:1 if funding margins compress and securitization volumes rebound within 6–12 months.
• Relative-value pair: go long RDN / short MTG (or ESNT) dollar‑neutral, horizon 6–12 months — rationale: RDN better positioned to absorb tighter secured funding via capital markets while peers with higher funding concentration have greater downside if MBS spreads widen; unwind if pair diverges >15% intraday or after new reserve guidance.
• Event hedge: buy 3–6 month protection on short-dated IG RMBS tranches or increase cash/short-duration treasuries if MBS primary market spreads widen >50bps — this limits contagion risk to the equity book and preserves optionality to add on funding clarity.